Veritas Investment Management (UK) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$15.8M |
| 2 |
Franco-Nevada
FNV
|
+$5.76M |
| 3 |
Waters Corp
WAT
|
+$3.62M |
| 4 |
UnitedHealth
UNH
|
+$3.28M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$12.8M |
| 2 |
Cognizant
CTSH
|
+$3.2M |
| 3 |
BP
BP
|
+$914K |
| 4 |
Microsoft
MSFT
|
+$723K |
| 5 |
Cisco
CSCO
|
+$317K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.82% |
| 2 | Technology | 20.32% |
| 3 | Financials | 16.85% |
| 4 | Communication Services | 15.17% |
| 5 | Energy | 6.96% |
Similar funds
Veritas Investment Management (UK)'s Q4 2016 Portfolio in Review
As of Q4 2016, Veritas Investment Management (UK) held 59 positions worth $243M, up 18% from $207M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Veritas Investment Management (UK) deployed $29.7M of net new capital in Q4 2016, opening 8 new positions and adding to 12 existing holdings. Its largest new stake was Thermo Fisher Scientific: 107,495 shares worth $15.2M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Cognizant, an estimated $3.2M trimmed.
- Veritas Investment Management (UK)'s largest Q4 2016 buy was Thermo Fisher Scientific: 107,495 shares worth $15.2M.
- Veritas Investment Management (UK) added most to Franco-Nevada in Q4 2016, an estimated $5.76M increase.
- Veritas Investment Management (UK)'s biggest Q4 2016 reduction was Cognizant, cutting an estimated $3.2M.
- Veritas Investment Management (UK) fully exited Oracle in Q4 2016, selling an estimated $12.8M.
- Veritas Investment Management (UK)'s ten largest holdings make up 70% of its $243M portfolio in Q4 2016.
- Veritas Investment Management (UK) opened 8 new positions and closed 12 in Q4 2016.
- Veritas Investment Management (UK)'s portfolio value rose 18% quarter-over-quarter to $243M.
Based on Veritas Investment Management (UK)'s 13F filing for Q4 2016, filed 31 Jan 2017.